A new center at the University of California, Irvine is working to better serve patients and healthcare providers by using artificial intelligence (AI).

In the first-of-its-kind FDA-approved study, researchers from the University of Maryland School of Medicine are using MRI-guided focused ultrasound to open the blood-brain barrier to help deliver drugs for patients with glioblastoma.

iCAD announced that its PowerLook Density Assessment 3.4 solution has gained FDA clearance. The software, compatible with iCAD’s digital breast tomosynthesis solutions, uses artificial intelligence to assess patients’ breast density.

The center will serve as a common space for University of California, Irvine (UCI) faculty, physicians and researchers to collaborate on translating artificial intelligence (AI)-based concepts into clinical tools to improve all aspects of healthcare.

A new artificial intelligence (AI) algorithm developed by researchers from the Lawson Health Research Institute in Ontario, Canada and The Mind Research Network in Albuquerque, New Mexico, could help predict whether a patient will successfully respond to medication for a mood disorder.  

Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced Wednesday, August 8, that it has gained FDA clearance for its brain solution that helps radiologists flag acute intracranial hemorrhage (ICH) cases using artificial intelligence (AI).

A team of Russian researchers has developed a novel MRI coil capable of producing images with three times the resolution of commercial varieties, according to a recent NMR in Biomedicine study.

Canon Medical Research Europe, based in Edinburgh, Scotland, was awarded $180,000 to develop an artificial intelligence (AI)-based medical imaging technology prototype that can recognize, assess and measure asbestos-related cancer tumors, according to a report published Aug. 6 by Scottish Business Insider.